Global Pharma News
WHO prequalifies first monoclonal antibody – tocilizumab – to treat COVID-19
Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody,...
Read more
Bayer will discontinue phase II development candidate eliapixant
Review of development program led to reassessment of benefit-risk ratio in all four potential indications for...
Read more
FDA approves Roche’s Vabysmo, the first bispecific antibody for the eye, to treat two leading causes of vision loss
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME)...
Read more
Bayer appoints Christine Roth as new Head of Oncology Strategic Business Unit at Pharmaceuticals Division
Bayer today announced Christine Roth as the new Head of the Oncology Strategic Business Unit at...
Read more
New Zealand’s Medsafe Grants Provisional Approval for Novavax’ COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution in New Zealand...
Read more
Sanofi unveils new corporate brand and logo
Sanofi today unveiled a new bold and unifying corporate brand that supports the modernization and transformation...
Read more
US FDA Approves Treatment for adults with rare type of Anemia
FDA has approved Enjaymo (sutimlimab-jome) infusion to decrease the need for red blood cell transfusion due to hemolysis...
Read more
Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches
Amneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled...
Read more
argenx to regain global rights to cusatuzumab
argenx SE announced it will regain worldwide rights to its anti-CD70 antibody cusatuzumab from Cilag GmbH...
Read more
U.S. FDA Accepts PharmaEssentia’s BLA Resubmission for ropeginterferon alfa-2b-njft
U.S. FDA Accepts PharmaEssentia’s BLA Resubmission for ropeginterferon alfa-2b-njft for the Treatment of Polycythemia Vera
Read more
Recent News
